Pre-Departure PCR Testing
Polymerase Chain Reaction (PCR) testing enables detecting viral nucleic acid to identify those with an active COVID-19 infection.
Sample requirement: Saliva, Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab and Oropharyngeal Mid-Turbinate (OPMT) Swab.
Book your appointment with clinic authorized to offer COVID-19 PCR test
Sample processed at iGene Laboratory
Results reported back to the ordering clinician
Your digital certificate and report will be emailed to you by the clinic.
|Name||SHALOM CLINIC & SURGERY|
|Address||123 Bukit Merah Lane 1, Alexander Village #01-104 Singapore 150123|
|Weekdays||9am to 12.30pm
2pm to 4.45pm
|Name||MEDICAL & DENTAL CENTRE @ COMMONWEALTH|
|Address||Blk 88 Tanglin Halt Road, Commonwealth View #01-03 Singapore 141088|
|Weekdays||8.30am to 12pm
1.30pm to 5pm
6.30pm to 9pm (Only on Mon & Wed)
|Saturday||9am to 2pm|
COVID-19 Serology Testing
Serology testing enables detecting antibody protein markers to identify those with an active COVID-19 infection.
Sample requirement: Blood.
Easy Testing for Travellers
Travellers to ensure eligibility for testing, where required. Please refer to ICA website for more information.
Specimen will be collected at partner clinics islandwide. Refer to key partner list for partner clinics and locations in Singapore
Obtain your digital certificate and the report from the clinic.
Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI). There are many different types of HPV. Some types can cause health problems including cervical cancer in women.
Evolution of Screening and Diagnosis
The mRNA testing technology distinguishes itself from the DNA testing technology in terms of clinical outcomes.1,2,3
Disease Progression & mRNA Expression
HPV DNA levels may decrease, however, our assay targets E6/E7 mRNA, which increases with disease progression. HPV mRNA testing can screen for cervical carcinoma condition.4
The assay can identify 14 high-risk types (16/18/31/33/35/39/45/51/52/56/58/59/66/68) of HPV infections.
Liquid Based Cytology
HPV mRNA testing with ThinPrep specimen collection kit for greater patient comfort.
1. ThinPrep 2000 System [Instructions for Use]. MAN-02624-001 Rev. 004. Marlborough, MA: Hologic, Inc.; 2017
2. Wright TC, et al. Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening. Obstet Gynecol 2004;103(2):304-309.
3. Aptima HPV Assay [package insert]. AW-12820, Rev 004. San Diego, CA: Hologic, Inc.; 2019.
4. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006 May;110(5):525-41. doi: 10.1042/CS20050369. PMID: 16597322
Sexually Transmitted Infections (STI) Testing
Overlapping symptoms make vaginitis clinical diagnosis a challenge.1
Co-infections and overlapping symptoms make clinical diagnosis a challenge. Up to 30% diagnosed with a BV co-infection are also co-infected with Candida species.
Some types of vaginitis are transferred through sexual activity, while others arise because of an imbalance in the bacterial or fungal makeup of the vaginal microbiome.2 Combined, bacterial vaginosis (BV), candida vaginitis (commonly known as a yeast infection, CV), and trichomoniasis (Trichomonas vaginalis, TV).
If these conditions are left untreated, it could l had to prolonged infection, increased risk of acquiring new STI and more long term conditions.3,4
Chlamydia Trachomatis and Neisseria Gonorrhoeae (CTNG) Screening
Chlamydia (CT) and gonorrhea (NG) can have serious long-term consequences including pelvic inflammatory disease (PID), ectopic pregnancy and infertility. Testing and treatment are critical to protecting sexual and reproductive health.5
Detection of up to SIX infections with just one vaginal swab:
BV, TV, gonorrhea, chlamydia, C.species and C.glabrata.
1. Cartwright CP, et al. Comparison of nucleic acid amplification assays with BD affirm for diagnosis of vaginitis in symptomatic women. J Clin Microbiol 2013 Nov; 51(11): 3694-9.
2. Paladine HL. Vaginitis: Diagnosis and Treatment. Am Fam Physician. Am Fam Physician. 2018 Mar 1;97(5):321-329.
3. Allsworth J, et al. Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis. 009;36(12):738-744.
4. MMWR, Vol. 64, Nr. 3. Sexually transmitted diseases treatment guidelines, June 5, 2015.
5. Workowski, et al. Sexually Transmitted Infections Treatment Guidelines 2021. MMWR Recomm Rep 2021;70.